Aprea Therapeutics, Inc. (APRE) |
| 1.46 -0.017 (-1.15%) 10-10 11:50 |
| Open: | 1.5 |
| High: | 1.51 |
| Low: | 1.45 |
| Volume: | 18,740 |
| Market Cap: | 9(M) |
| PE Ratio: | -0.63 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.66 |
| Resistance 1: | 1.55 |
| Pivot price: | 1.47 |
| Support 1: | 1.37 |
| Support 2: | 1.14 |
| 52w High: | 5.01 |
| 52w Low: | 1.37 |
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
Financials
| EPS | -14770000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -50.641 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -2.00 |
| Return on Assets (ttm) | 868.3 |
| Return on Equity (ttm) | -39.1 |
Company news
Thu, 28 Aug 2025
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference - The Manila Times
Thu, 28 Aug 2025
Clinical-Stage Cancer Drug Developer Aprea Therapeutics to Present Latest Updates at Major Investment Conference - Stock Titan
Tue, 12 Aug 2025
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times
Tue, 12 Aug 2025
Breakthrough: Aprea's Novel Cancer Drugs Show Disease Control in 10 Patients Across Two Clinical Trials - Stock Titan
Tue, 12 Aug 2025
Aprea Therapeutics Reports Promising Q2 2025 Results - TipRanks
Thu, 10 Jul 2025
Aprea Therapeutics Insiders Still US$86k Away From Original Investment Value - simplywall.st
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
